{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:24:04Z","timestamp":1785860644077,"version":"3.56.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017607","name":"Shenzhen Basic Research Program","doi-asserted-by":"publisher","award":["JCYJ20230807110417036"],"award-info":[{"award-number":["JCYJ20230807110417036"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Basic Research Program","doi-asserted-by":"publisher","award":["JCYJ20220530144606015"],"award-info":[{"award-number":["JCYJ20220530144606015"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405528"],"award-info":[{"award-number":["82405528"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20231077"],"award-info":[{"award-number":["20231077"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515220096"],"award-info":[{"award-number":["2022A1515220096"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.116007","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T07:57:02Z","timestamp":1765958222000},"page":"116007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hyperoside attenuates NASH-associated liver fibrosis by modulating Flot2\/TLR4 signaling and pyroptosis"],"prefix":"10.1016","volume":"169","author":[{"given":"Peng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2025.116007_bb0005","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.intimp.2025.116007_bb0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.116007_bb0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2025.116007_bb0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2025.116007_bb0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.28524","article-title":"The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health","volume":"64","author":"Rinella","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2025.116007_bb0050","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/hep.28584","article-title":"Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Lonardo","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.116007_bb0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116007_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.116007_bb0065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2025.116007_bb0070","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.intimp.2025.116007_bb0075","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116007_bb0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0085","doi-asserted-by":"crossref","first-page":"2377567","DOI":"10.1080\/19490976.2024.2377567","article-title":"Gut microbiota promotes macrophage M1 polarization in hepatic sinusoidal obstruction syndrome via regulating intestinal barrier function mediated by butyrate","volume":"16","author":"Zhao","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.intimp.2025.116007_bb0090","article-title":"The contribution of the gut-liver axis to the immune signaling pathway of NAFLD","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.116007_bb0095","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.116007_bb0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.116007_bb0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase Signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.intimp.2025.116007_bb0110","article-title":"Hyperoside as a potential natural product targeting oxidative stress in liver diseases","volume":"11","author":"Jang","year":"2022","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.intimp.2025.116007_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"2021","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.116007_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2025.116007_bb0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jare.2024.12.016","article-title":"Natural small molecule hinokitone mitigates NASH fibrosis by targeting regulation of FXR-mediated hepatocyte apoptosis","volume":"76","author":"Ma","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2025.116007_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733808","article-title":"Hyperoside suppresses renal inflammation by regulating macrophage polarization in mice with type 2 diabetes mellitus","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.116007_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155173","article-title":"Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi capsule for treating non-alcoholic fatty liver disease","volume":"123","author":"Zhu","year":"2024","journal-title":"Phytomedicine"},{"issue":"7\u20138","key":"10.1016\/j.intimp.2025.116007_bb0140","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12272-025-01560-2","article-title":"Silybin inhibits succinate production and secretion in hepatocytes to reverse liver fibrosis","volume":"48","author":"Yang","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2025.116007_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112361","article-title":"Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"248","author":"Hu","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/07391102.2020.1815580","article-title":"Identify thrombin inhibitor with novel skeleton based on virtual screening study","volume":"40","author":"Tang","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"8","key":"10.1016\/j.intimp.2025.116007_bb0155","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2. 0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0160","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsletter on protein crystallography."},{"issue":"12","key":"10.1016\/j.intimp.2025.116007_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004586","article-title":"AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility","volume":"11","author":"Ravindranath","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116007_bb0170","first-page":"198","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Salomon-Ferrer","year":"2013","journal-title":"Wiley Interdiscip. Rev.: Comput. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.116007_bb0175","series-title":"Gaussian 09, Revision d. 01, Gaussian. Inc, Wallingford CT","volume":"201","author":"Frisch","year":"2009"},{"key":"10.1016\/j.intimp.2025.116007_bb0180","first-page":"U403","article-title":"Antechamber: an accessory software package for molecular mechanical calculations","volume":"222","author":"Wang","year":"2001","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.intimp.2025.116007_bb0185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2025.116007_bb0190","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"issue":"6","key":"10.1016\/j.intimp.2025.116007_bb0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.116007_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156559","article-title":"JiGuCao capsule formula alleviates metabolic fatty liver disease by regulating the gut\u2013liver axis and lipid metabolism","volume":"140","author":"Qi","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.RES.0000108263.74520.15","article-title":"Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture","volume":"94","author":"Rahkonen","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2025.116007_bb0210","article-title":"Erratum: Cardiac RKIP induces a beneficial \u03b2-adrenoceptor\u2013dependent positive inotropy","volume":"22(2):217","author":"Schmid","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imr.13196","article-title":"The leukotriene B4 receptors BLT1 and BLT2 as potential therapeutic targets","volume":"317","author":"Yokomizo","year":"2023","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2025.116007_bb0220","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.biocel.2013.04.005","article-title":"5-Hydroxyeicosatetraenoic acid and leukotriene D4 increase intestinal epithelial paracellular permeability","volume":"45","author":"Rodr\u00edguez-Lagunas","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2025.116007_bb0225","series-title":"Fecal calprotectin and intestinal metabolites: what is their importance in the activity and differentiation of patients with inflammatory bowel diseases? ABCD Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)","author":"Lins","year":"2025"},{"issue":"D1","key":"10.1016\/j.intimp.2025.116007_bb0230","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.intimp.2025.116007_bb0235","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.116007_bb0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/JIR.S141220","article-title":"Spotlight on the NLRP3 inflammasome pathway","author":"Groslambert","year":"2018","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.116007_bb0245","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: activation and regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem. Sci."},{"issue":"14","key":"10.1016\/j.intimp.2025.116007_bb0250","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.116007_bb0255","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40139-015-0089-8","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis: updated","volume":"3","author":"Dewidar","year":"2015","journal-title":"Curr. Pathobiol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.116007_bb0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"10.1016\/j.intimp.2025.116007_bb0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S002966511000162X","article-title":"Flavonoids as anti-inflammatory agents","volume":"69","author":"Serafini","year":"2010","journal-title":"Proc. Nutr. Soc."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.32221","article-title":"Breviscapine alleviates NASH by inhibiting TGF-\u03b2-activated kinase 1-dependent signaling","volume":"76","author":"Lan","year":"2022","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.intimp.2025.116007_bb0280","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1002\/ptr.8285","article-title":"Flavonoids for treating pulmonary fibrosis: present status and future prospects","volume":"38","author":"Sharma","year":"2024","journal-title":"Phytother. Res."},{"issue":"25","key":"10.1016\/j.intimp.2025.116007_bb0285","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2174\/0929867322666150805094940","article-title":"Flavonoids and related compounds in non-alcoholic fatty liver disease therapy","volume":"22","author":"Pisonero-Vaquero","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2025.116007_bb0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"de Carvalho","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2025.116007_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091475","article-title":"Mitochondria and the NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis","volume":"11","author":"Torres","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.intimp.2025.116007_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092732","article-title":"NLRP3 inflammasome and IL-33: novel players in sterile liver inflammation","volume":"19","author":"Neumann","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.116007_bb0305","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1002\/ptr.8274","article-title":"Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease? A systematic review, meta-analysis, and meta-regression","volume":"38","author":"Arag\u00f3n-Vela","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2025.116007_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108593","article-title":"Berberine prevents NAFLD and HCC by modulating metabolic disorders","volume":"254","author":"Lin","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.116007_bb0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fmicb.2018.00061","article-title":"Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease","volume":"9","author":"Saltzman","year":"2018","journal-title":"Front. Microbiol."},{"issue":"18","key":"10.1016\/j.intimp.2025.116007_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.116007_bb0330","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev-biochem-030222-120000","article-title":"The art and science of molecular docking","volume":"93","author":"Paggi","year":"2024","journal-title":"Annu. Rev. Biochem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:11:30Z","timestamp":1777619490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925019964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":66,"alternative-id":["S1567576925019964"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116007","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperoside attenuates NASH-associated liver fibrosis by modulating Flot2\/TLR4 signaling and pyroptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116007"}}